Novo Nordisk's weight loss pill could give the company's numbers a big boost this year.

The target action date for orforglipron is now April 10.

We’ve all heard of Ozempic by now. It’s only licensed for use as a diabetes treatment in the UK and US, but it's widely used ‘off label’ to help people lose weight. So much so, in fact, that its name ...

It’s a tough pill to swallow. There are countless supplements and pantry staples out there that swear to help people slim down, from apple cider vinegar shots to “nature’s Ozempic”. But one popular ...

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 medication for ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

People with diabetes who also suffer from heart failure were at less risk of serious health issues, including hospitalisation and even death, when they took an Ozempic-like pill to manage their health ...

Analysts say GLP-1 weight-loss drugs could make airfare cheaper by reducing fuel costs as passengers get thinner. Experts ...

Danish drugmaker Novo Nordisk said the first-of-its kind oral pill will offer 1.5 and 4 milligram doses at $149 per month for ...

Add Yahoo as a preferred source to see more of our stories on Google. In the last week of December, while most of the U.S. was still in holiday mode, Novo Nordisk’s plant in North Carolina was ...